Skip to main content
. Author manuscript; available in PMC: 2017 Sep 1.
Published in final edited form as: Mol Cancer Ther. 2016 Jul 7;15(9):2107–2118. doi: 10.1158/1535-7163.MCT-16-0241

Figure 3.

Figure 3

Combination of enzalutamide and geldanamycin led to cytoplasmic localization of AR. (a-d) LNCaP (A), C4-2 (B), 22RV1 (C) and MR49F (D) cells were treated as indicated for 24 hr, then subjected for immunofluorescence (IF) staining against AR.